Integrated allergy platform Curex combines at-home diagnostics, immunotherapy and telemedicine, signaling a sales opportunity to upsell integrated digital health tools, remote monitoring capabilities, and bundled allergy care services to healthcare systems, employers, and payer partners seeking a turnkey patient-centric solution.

Scale potential With 51-200 employees and revenue in the mid six figures to low seven figures range, Curex appears poised for rapid growth; focus sales efforts on partnerships with mid-market clinics, health plans, and direct-to-consumer channels to accelerate revenue expansion and channel diversification.

Digital first Existing tech stack (Webflow, Tailwind CSS, analytics tools) suggests readiness for white-labeled or co-branded digital experiences; propose customizable patient portals, reporting dashboards for clinicians, and API integrations to embed Curex services into partner platforms.

Competitive positioning Position Curex as a zero-allergies vision and affordable sublingual immunotherapy, presenting opportunities to collaborate with allergy clinics, primary care networks, and specialty pharmacies to expand access, while differentiating on ease of use and patient-centric care.

Market expansion The emphasis on at-home diagnostics and telemedicine aligns with trends toward remote chronic condition management; target corporate wellness programs, direct-to-employer contracts, and regional health systems seeking scalable allergy care solutions to reduce in-clinic visits and improve outcomes.